These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 7811051)

  • 21. [Comparative in vitro activity of a new macrolide RU 28965 and of erythromycin against Chlamydia trachomatis].
    Dutilh B; de Barbeyrac B; Lafferrière C; Bébéar C
    Pathol Biol (Paris); 1986 May; 34(5):445-7. PubMed ID: 3534718
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro evaluation of CP-62,993, erythromycin, clindamycin, and tetracycline against Chlamydia trachomatis.
    Walsh M; Kappus EW; Quinn TC
    Antimicrob Agents Chemother; 1987 May; 31(5):811-2. PubMed ID: 3038010
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Bacteriostatic and bactericidal activities of cyclines, macrolides and fluoroquinolones against Chlamydia trachomatis].
    Dailloux M; Villemain P
    Pathol Biol (Paris); 1992 May; 40(5):455-60. PubMed ID: 1495827
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Studies on uptake of macrolide antibiotics by Chlamydia host cell].
    Kosugi-Shiritani Y; Hagiwara T; Yamazaki S
    Kansenshogaku Zasshi; 1991 Nov; 65(11):1446-50. PubMed ID: 1791345
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative in vitro activity of garenoxacin against Chlamydia spp.
    Donati M; Pollini GM; Sparacino M; Fortugno MT; Laghi E; Cevenini R
    J Antimicrob Chemother; 2002 Sep; 50(3):407-10. PubMed ID: 12205067
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro activity of azithromycin (CP-62,993) against Chlamydia trachomatis and Chlamydia pneumoniae.
    Agacfidan A; Moncada J; Schachter J
    Antimicrob Agents Chemother; 1993 Sep; 37(9):1746-8. PubMed ID: 8239579
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro effects of spectinomycin and ceftriaxone alone or in combination with other antibiotics against Chlamydia trachomatis.
    Shang S; Xia L; Zhong M; Zhang J; Zhao J; Gong X; Mabey D; Wang Q
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1584-6. PubMed ID: 15793145
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative in vitro evaluation of dirithromycin tested against recent clinical isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae, including effects of medium supplements and test conditions on MIC results.
    Biedenbach DJ; Jones RN; Lewis MT; Croco MA; Barrett MS
    Diagn Microbiol Infect Dis; 1999 Apr; 33(4):275-82. PubMed ID: 10212755
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Minimum inhibitory and minimal lethal concentration against Chlamydia trachomatis dependent on the time of addition and the duration of the presence of antibiotics.
    Notomi T; Ikeda Y; Nagayama A
    Chemotherapy; 1999; 45(4):242-8. PubMed ID: 10394006
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antimicrobial Sensitivity Profile of Chlamydia trachomatis isolates from Croatia in McCoy Cell Culture System and Comparison with the Literature.
    Mestrović T; Ljubin-Sternak S; Sviben M; Bedenić B; Vranes J; Markotić A; Skerk V
    Clin Lab; 2016; 62(3):357-64. PubMed ID: 27156324
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tonsillar tissue penetration of dirithromycin after multiple doses.
    Benson JM; Arnold J; Manning SC; Coleman DL; Sides GD; Conforti PM; Lemon E; Watkins VS
    J Clin Pharmacol; 1996 Sep; 36(9):832-7. PubMed ID: 8889904
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro evaluation of activities of azithromycin, clarithromycin and sparfloxacin against Chlamydia trachomatis.
    Lefèvre JC; Escaffre MC; Courdil M; Lareng MB
    Pathol Biol (Paris); 1993 Apr; 41(4):313-5. PubMed ID: 8233628
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative in vitro susceptibility of a tetracycline-resistant Chlamydia trachomatis strain isolated in Toulouse (France).
    Lefèvre JC; Lépargneur JP
    Sex Transm Dis; 1998 Aug; 25(7):350-2. PubMed ID: 9713914
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chlamydia trachomatis: in vitro susceptibility of genital and ocular isolates to some quinolones, amoxicillin and azithromycin.
    Børsum T; Dannevig L; Størvold G; Melby K
    Chemotherapy; 1990; 36(6):407-15. PubMed ID: 1963393
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro activity of CEM-101, a new fluoroketolide antibiotic, against Chlamydia trachomatis and Chlamydia (Chlamydophila) pneumoniae.
    Roblin PM; Kohlhoff SA; Parker C; Hammerschlag MR
    Antimicrob Agents Chemother; 2010 Mar; 54(3):1358-9. PubMed ID: 20038627
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of the in vitro susceptibility of clinical isolates of chlamydia trachomatis with serovar and duration of antibiotic exposure.
    Zheng H; Xue Y; Bai S; Qin X; Lu P; Yang B
    Sex Transm Dis; 2015 Mar; 42(3):115-9. PubMed ID: 25668641
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of dirithromycin.
    Sides GD; Cerimele BJ; Black HR; Busch U; DeSante KA
    J Antimicrob Chemother; 1993 Mar; 31 Suppl C():65-75. PubMed ID: 8478313
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chlamydia trachomatis antimicrobial susceptibility in colorectal and endocervical cells.
    Foschi C; Salvo M; Cevenini R; Marangoni A
    J Antimicrob Chemother; 2018 Feb; 73(2):409-413. PubMed ID: 29077843
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro activity of dirithromycin (LY 237216) compared with activities of other macrolide antibiotics.
    Yu KW; Neu HC
    Antimicrob Agents Chemother; 1990 Sep; 34(9):1839-42. PubMed ID: 2126695
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [In vitro inhibition of Chlamydia trachomatis growth by liposome-encapsulated cyclines].
    Sangaré L; Morisset R; Ravaoarinoro M
    Pathol Biol (Paris); 2001 Feb; 49(1):53-6. PubMed ID: 11265224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.